Lv1
26 积分 2026-02-04 加入
CD20+ T cells: an emerging T cell subset in human pathology
11小时前
待确认
CD20 (Pan-B Cell Antigen) Expression on Bone Marrow-Derived T Cells
12小时前
已完结
Propensity score matching analysis comparing the efficacy of Ruxolitinib to historical controls in second-line or beyond treatment for chronic GvHD after steroid failure
15天前
已完结
Drug-Induced Progressive Multifocal Leukoencephalopathy (PML): A Systematic Review and Meta-Analysis
22天前
已完结
Regarding the “Efgartigimod versus standard of care in new-onset AChR subtype generalized myasthenia gravis: A prospective cohort study”
1个月前
已完结
Efgartigimod versus standard of care in new-Onset AChR subtype generalized myasthenia gravis: A prospective cohort study
1个月前
已完结
Single-cell profiling of immune reset in patients with refractory generalized myasthenia gravis receiving autologous CD19/BCMA CAR-T cell therapy
1个月前
已完结
Immune reset and immune retune: approaching cure?
1个月前
已完结
Factors associated with acute exacerbations of myasthenia gravis
2个月前
已完结
Rethinking rituximab in neuroimmunology: Real-world efficacy, cost-effectiveness, and long-term remission
2个月前
已完结
皖公网安备34019202002308
